You are here

Article info

Article menu
Download PDFPDF
Original article
NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas

Authors

  1. Correspondence to Dr Ashley Cimino-Mathews, Department of Pathology, The Johns Hopkins Hospital, 401 North Broadway Street, Weinberg 2242, Baltimore, MD 21231, USA; acimino1{at}jhmi.edu
View Full Text

Citation

Asch-Kendrick RJ, Samols MA, Lilo MT, et al
NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas
Journal of Clinical Pathology 2014;67:768-771.

Publication history

  • Received March 12, 2014
  • Revised June 20, 2014
  • Accepted June 22, 2014
  • First published July 4, 2014.
Online issue publication 
August 11, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions